What are Mission Vision & Core Values of AddLife AB Company?

How does AddLife AB define its purpose and direction?

In the complex field of life sciences, AddLife AB’s strategic statements guide a decentralized group of over 80 subsidiaries toward improved clinical outcomes and research efficiency. They align local autonomy with a unified purpose, shaping acquisitions, capital allocation and talent decisions.

AddLife’s mission focuses on enabling better healthcare through distribution, service and solutions; the vision emphasizes trusted expertise across the Nordics, DACH and Benelux; core values stress reliability, specialist knowledge and long-term value creation. See AddLife AB Porter's Five Forces Analysis

Mission: To add value as a leading independent Life Science player in Europe by curating high‑end niche solutions for healthcare, research and pharma, ensuring technical support, training and uptime for critical diagnostics and medtech.

Customer‑centric focus

Prioritizes clinicians, labs and hospitals with tailored product portfolios and support.

Independent sourcing

Maintains independence from single manufacturers to select best‑in‑class global suppliers.

High‑end niche markets

Targets specialized segments where technical expertise is required for sales and service.

Labtech execution

Delivers integrated diagnostics (blood gas, molecular) with 24/7 uptime through training and support.

Medtech impact

Supplies specialized surgical and home‑care equipment that improves patient quality of life.

Value orientation

Combines clinical benefit with economic value through curated product selection and service models.

AddLife ABs mission is executed via Labtech and Medtech segments; in 2024 the group reported revenue of SEK 6.3 bn and an adjusted EBITA margin of 8.1%, reflecting focus on niche, high‑margin solutions and technical service that underpin the company purpose and business philosophy; see Brief History of AddLife AB

Companys’s vision focuses on driving clinical and shareholder value through a disciplined buy-and-build strategy, expanding beyond the Nordics into Central and Eastern Europe while addressing ageing-population healthcare needs.

European leadership

Targeting market leadership across Europe via acquisitions and organic growth; 2024–2025 expansion accelerated presence in CEE.

Value creation

Emphasises both clinical value for patients and financial value for shareholders through disciplined integration.

Patient impact

Shifts from distribution to partnership in care delivery to improve outcomes and efficiency in diagnostics and home care.

Strategic growth

Buy-and-build model supported by historically strong EBITA CAGR and successful niche integrations.

Demographic alignment

Aligns with ageing European demographics and rising demand for cost-effective diagnostics and home-care solutions.

measurable targets

Focus on sustained EBITA growth, margin improvements after integrations, and scalable regional footprint expansion.

The vision remains realistic and aspirational: building on past EBITA CAGR and 2024–2025 CEE expansion to become a European life-science leader improving patient care and shareholder returns. Read more in Target Market of AddLife AB

AddLife AB core values guide daily decisions across its Medtech and lab-diagnostics businesses, shaping culture and commercial priorities. These values—Simplicity, Responsibility, Drive and Business Skills—support rapid, ethical growth and measurable financial performance.

Simplicity

Lean structures and empowered subsidiaries enable fast, low‑bureaucracy decisions; this supports local customization and quicker market responses, helping sustain higher operating agility.

Responsibility

Focus on ethical conduct and sustainability, evidenced by 2025 initiatives to increase recycled packaging and strengthen ESG audits across the supply chain, reducing environmental impact.

Drive

Entrepreneurial mindset encouraging subsidiaries to pursue growth and innovation, such as expansion into digital pathology and AI diagnostics to capture emerging market opportunities.

Business Skills

Commercial discipline requiring value‑adding decisions, with subsidiaries held to margin and working‑capital targets to ensure profitability and scalable returns.

Read next: how AddLife AB mission statement and AddLife AB vision influence strategic decisions and resource allocation across the group; see also Owners & Shareholders of AddLife AB

Mission and vision statements steer AddLife AB’s strategic choices by setting priorities for acquisitions, product development and capital allocation. They create a shared framework that aligns decentralized operations across markets toward scalable growth.

Strategic North Star

AddLife AB vision drives pursuit of European leadership in Life Science distribution and solutions.

• The mission emphasizes providing high-quality Life Science solutions across diagnostics and laboratory equipment.
• Vision prioritizes scale in key European markets, notably the DACH region and Nordics.
• Core values promote decentralization, entrepreneurship and long-term value creation.
• Acquisitions focus on value-creating, specialist distributors with strong local market positions.

Acquisition-Led Growth

Between 2023 and 2025 AddLife completed several acquisitions in the DACH region to expand market footprint and technical capabilities.

Service-as-a-Product

Product strategy shifted toward bundled diagnostics workflows, combining hardware, software and maintenance contracts.

Financial Targets

Management targets an EBITA growth of 15 percent over a business cycle and emphasizes a high Return on Working Capital (P/WC).

Decentralized Model

Corporate governance relies on mission and values as a common language to enable independent local leadership within an overarching strategy.

Performance Metrics

Success is measured by EBITA margins, P/WC and the revenue contribution from service contracts versus pure hardware sales.

Board Emphasis

The Board highlights alignment with AddLife AB mission statement and core values as essential for long-term planning and integration of acquisitions.

The mission and vision shape acquisition criteria, product strategy and KPIs—read the next chapter: Core Improvements to Company's Mission and Vision to see actionable changes and targets.

Influence: The mission and vision statements are the primary filters through which AddLife evaluates its business strategy, particularly its aggressive acquisition model. A strategic decision directly guided by the vision of European leadership was the acquisition of several specialized distributors in the DACH region between 2023 and 2025, which expanded the company's footprint in the largest European healthcare market. This expansion was not just about size, but about acquiring 'value-creating' entities that align with the mission of providing high-quality Life Science solutions. The influence on product development is seen in the shift toward 'service-as-a-product' models, where AddLife provides not just the hardware but the entire diagnostic workflow, including software and maintenance. Success metrics reflecting this alignment include an EBITA growth target of 15 percent over a business cycle and a focus on a high Return on Working Capital (P/WC). Leadership, including the Board of Directors, frequently emphasizes that the decentralized model is only possible because the mission and values act as a 'common language' that ensures long-term planning remains consistent across diverse geographic regions. Growth Strategy of AddLife AB

Four targeted improvements can modernize AddLife AB's mission and vision to reflect 2025 realities and stakeholder expectations. These refinements focus on digital transformation, sustainability, patient-centricity, and measurable impact metrics.

Embed Digital Transformation and Data-Driven Outcomes

Explicitly reference 'Digital Transformation' and 'Data-Driven Insights' in the AddLife AB mission statement to signal commitment to AI-enabled diagnostics, remote monitoring, and analytics-driven product development.

Adopt a Clear Sustainability and Circular Economy Pledge

Integrate 'sustainable healthcare' into AddLife AB vision to address MedTech waste reduction, set carbon targets, and align with ESG investor expectations and public procurement rules.

Center Patient-Centricity and Personalized Medicine

Update AddLife AB core values to emphasize patient outcomes, personalized medicine, and interoperability to support remote care and precision therapies.

Introduce Measurable Targets and Transparency

Include quantifiable goals in the AddLife AB vision—for example, reducing scope 1–3 emissions by 30% by 2030 or achieving 20% revenue from digital services by 2028—to improve accountability and investor confidence.

Improvements: While AddLife's mission and vision are robust, there are opportunities for refinement to better reflect the 2025 technological landscape; the current statements could be strengthened by explicitly mentioning 'Digital Transformation' or 'Data-Driven Insights.' As healthcare moves toward personalized medicine and remote monitoring, incorporating these elements into the mission would signal a commitment to the next generation of Life Science; for example, a refinement like 'Adding value through digital and physical Life Science solutions' would better align with the increasing importance of medical data. Furthermore, compared to some global competitors who have integrated 'Sustainability' or 'Patient-Centricity' directly into their primary vision statements, AddLife’s vision is somewhat traditional; a growth opportunity exists in more clearly articulating their role in the circular economy, particularly in the MedTech sector where medical waste is a significant concern, and adapting the vision to include 'sustainable healthcare' would resonate with ESG-focused investors and public sector procurement requirements. Read related analysis in Competitors Landscape of AddLife AB